Azusa Nagao, M.D., M.Sc., serves as a hematologist at Ogikubo hospital, Tokyo, Japan that is the biggest hemophilia treatment center. Dr Nagao’s clinical research is focused on problems of women and girls bleeding disorders, ageing problems of hemophilia patients, and musculoskeletal ultrasound systems. Even though Dr Nagao is a young investigator, she has authored and co-authored more than 20 scientific publications, been a speaker at many national and international meetings and congresses.

Dr Azusa Nagao has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Bayer, Chugai, CSL, Fujimoto, JB, KMB, Novo Nordisk, Pfizer, Sanofi and Takeda.